Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy, Safety and Tolerability of Modified-Release Methylphenidate (MPH-MR) in Chinese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)
CNS Drugs · 2025
DOI: 10.1007/s40263-024-01136-6 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift CNS Drugs, 2025. Verfasst von Yi Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Anding Hospital of Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Methylphenidate, Central Nervous System Stimulants. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MEDICE Arzneimittel Pütter GmbH & Co. KG.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Beijing Anding Hospital of Capital Medical University, Beijing, China.
- Beijing Huilongguan Hospital, Beijing, China.
- The second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
- The first Hospital of Jilin University, Changchun, Jilin, China.
- MEDICE Arzneimittel Pütter GmbH & Co. KG, Iserlohn, Germany.
- MEDICE Arzneimittel Pütter GmbH & Co. KG, Iserlohn, Germany. r.ammer@medice.de.
Förderung
- MEDICE Arzneimittel Pütter GmbH & Co. KG
Zitieren
APA
Zheng, Y., Liu, H., Wang, X., Li, H., Ruhmann, M., Mayer, A., Dangel, O., & Ammer, R. (2025). Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy, Safety and Tolerability of Modified-Release Methylphenidate (MPH-MR) in Chinese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD). CNS Drugs. https://doi.org/10.1007/s40263-024-01136-6
Vancouver
Zheng Y, Liu H, Wang X, Li H, Ruhmann M, Mayer A, et al. Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy, Safety and Tolerability of Modified-Release Methylphenidate (MPH-MR) in Chinese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD). CNS Drugs. 2025. doi:10.1007/s40263-024-01136-6
BibTeX
@article{Zheng2025,
author = {Zheng, Yi and Liu, Huaqing and Wang, Xiuxia and Li, Haibo and Ruhmann, Michaela and Mayer, Anke and Dangel, Oliver and Ammer, Richard},
title = {Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy, Safety and Tolerability of Modified-Release Methylphenidate (MPH-MR) in Chinese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)},
journal = {CNS Drugs},
year = {2025},
doi = {10.1007/s40263-024-01136-6}
}
EUVIMED